Treatment guidelines in psoriatic arthritis
- PMID: 32159790
- PMCID: PMC7065461
- DOI: 10.1093/rheumatology/kez383
Treatment guidelines in psoriatic arthritis
Abstract
Psoriatic arthritis (PsA) is a complex inflammatory musculoskeletal and skin disease. The treatment of PsA has changed substantially over the past 10 years. Clinical practice guidelines are developed to help busy clinicians rapidly integrate evolving knowledge of therapeutic management into practice. In this review, we compare PsA treatment recommendations or guidelines developed by one national organization [ACR and National Psoriasis Foundation (NPF) in 2018], one regional organization (EULAR in 2015), and one international organization (the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis in 2015). We examine the development of guidelines in PsA more broadly and examine similarities and differences in the three sets of recommendations.
Keywords: outcomes; psoriatic arthritis; therapy; treat-to-target; treatment guidelines.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology.
References
-
- Coates LC, Kavanaugh A, Mease PJ. et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol 2016;68:1060–71. - PubMed
-
- Gossec L, Smolen JS, Ramiro S. et al. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis 2016;75:499–510. - PubMed
-
- Ritchlin CT, Colbert RA, Gladman DD.. Psoriatic arthritis. New Engl J Med 2017;376:2095–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous